Beate Betz

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

Jürgen Veeck, Dieter Niederacher, Han‐Xiang An et al. · Oncogene · 2006 · 254 citations

Tumor Biology, Aberrant Methylation, Breast Oncology +10

Recurrence and variability of germline <i>EPCAM</i> deletions in Lynch syndrome

Roland P. Kuiper, Lisenka E.L.M. Vissers, Ramprasath Venkatachalam et al. · Human Mutation · 2011 · 150 citations · Full text

Genome Instability, Gene Deletion Data, Epcam Gene +12

Association Between TAS2R38 Gene Polymorphisms and Colorectal Cancer Risk: A Case-Control Study in Two Independent Populations of Caucasian Origin

Maura Carrai, Verena Steinke, Pavel Vodička et al. · PLoS ONE · 2011 · 130 citations · Full text

Molecular Epidemiology, Epidemiology Of Cancer, Genetic Epidemiology +18

Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC

Monika Morak, Hans Konrad Schackert, Nils Rahner et al. · European Journal of Human Genetics · 2008 · 119 citations · Full text

Epigenetic Change, Genetics, Dna Methylation +16

Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

Aung Ko Win, James G. Dowty, Jeanette C. Reece et al. · The Lancet Oncology · 2021 · 112 citations · Full text

Lynch Syndrome, Retrospective Cohort Study, Cancer Risk +10